Metallic copper nanoparticles induce. apoptosis in a. human skin melanoma. A-375 cell line

被引:52
作者
Chakraborty, Ruchira [1 ]
Basu, Tarakdas [1 ]
机构
[1] Univ Kalyani, Dept Biochem & Biophys, Kalyani 741235, W Bengal, India
关键词
copper nanoparticle; apoptosis; caspase-9; skin cancer cell A-375; TMA-DPH; SILVER; DNA; CYTOTOXICITY; DEGRADATION; TOXICITY; RELEASE; CYCLE; ASSAY;
D O I
10.1088/1361-6528/aa57b0
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In two. earlier. communications (Chatterjee et al 2012 Nanotechnology 23 085103, Chatterjee et al 2014 Nanotechnology 25 135101), we reported the. development of a simple and unique method of synthesizing highly stable metallic copper nanoparticles. (Cu NPs) with high antibacterial activity. Here we report on. the cytotoxic potency of the NPs. against cancer cells. The value of the IC50 dose of. the Cu NPs. against human skin cancer cell A-375 was found to be 1.71 mu g ml(-1) only, which was much less than. values reported so far, and this concentration had no cytotoxic effect on normal white blood cells. The NPs caused (i) lowering of cell membrane rigidity, (ii) DNA degradation, (iii) chromosomal condensation, (iv) cell cycle arrest in the. G2/ M phase, (v) depolarization of the. mitochondrial membrane and. (vi) apoptosis of cells. Cellular apoptosis occurred in the caspase-9-mediated intrinsic pathway. This study revealed that our Cu NPs had high anticancer properties by killing tumor cells through the apoptotic pathway. Since. this particle has. high antibacterial activity, our Cu NPs might be developed in future as a. dual action drug-anticancer as well as antibacterial.
引用
收藏
页数:13
相关论文
共 20 条
  • [1] Copper Nanoparticles Induce Apoptosis and Oxidative Stress in SW480 Human Colon Cancer Cell Line
    Ghasemi, Parvin
    Shafiee, Gholamreza
    Ziamajidi, Nasrin
    Abbasalipourkabir, Roghayeh
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2023, 201 (08) : 3746 - 3754
  • [2] Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles
    Alarifi, Saud
    Ali, Daoud
    Alkahtani, Saad
    Verma, Ankit
    Ahamed, Maqusood
    Ahmed, Mukhtar
    Alhadlaq, Hisham A.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 983 - 993
  • [3] EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line
    Qin Shen
    Fen Tian
    Ping Jiang
    Yanqiu Li
    Li Zhang
    Jingjing Lu
    Jiawen Li
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 771 - 775
  • [4] EGCG Enhances TRAIL-mediated Apoptosis in Human Melanoma A375 Cell Line
    沈琴
    田芬
    蒋萍
    李艳秋
    张丽
    卢静静
    李家文
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2009, 29 (06) : 771 - 775
  • [5] EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line
    Shen, Qin
    Tian, Fen
    Jiang, Ping
    Li, Yanqiu
    Zhang, Li
    Lu, Jingjing
    Li, Jiawen
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (06) : 771 - 775
  • [6] Copper Nanoparticles Induce Apoptosis and Oxidative Stress in SW480 Human Colon Cancer Cell Line
    Parvin Ghasemi
    Gholamreza Shafiee
    Nasrin Ziamajidi
    Roghayeh Abbasalipourkabir
    Biological Trace Element Research, 2023, 201 : 3746 - 3754
  • [8] Mechanism of retinoid receptors in inhibiting proliferation and inducing apoptosis of human melanoma cell line A375
    Niu, XW
    Peng, ZH
    Feng, J
    Ma, HQ
    Liu, C
    Yuan, JY
    CHINESE MEDICAL JOURNAL, 2005, 118 (17) : 1482 - 1486
  • [9] Extracts of centipede Scolopendra subspinipes mutilans induce cell cycle arrest and apoptosis in A375 human melanoma cells
    Ma, Weina
    Liu, Rui
    Qi, Junpeng
    Zhang, Yanmin
    ONCOLOGY LETTERS, 2014, 8 (01) : 414 - 420
  • [10] Methoxy- and Fluoro-chalcone Derivatives Arrest Cell Cycle Progression and Induce Apoptosis in Human Melanoma Cell A375
    Henmi, Kayo
    Hiwatashi, Yoko
    Hikita, Eri
    Toyama, Naoya
    Hirano, Toshihiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (06) : 1109 - 1113